Tumor Associated Antigen Specific T Cells (TAA-T) With PD1 Inhibitor for Lymphoma

Condition:   Lymphoma Intervention:   Biological: TAA-T cells Sponsor:   Catherine Bollard Recruiting

Source: ClinicalTrials.gov - February 18, 2019 Category: Research Source Type: clinical trials